Drug Shortage Report for SEROQUEL XR

Last updated on 2017-05-16 History
Report ID 6371
Drug Identification Number 02300192
Brand name SEROQUEL XR
Common or Proper name quetiapine fumarate extended-release tablets
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) QUETIAPINE
Strength(s) 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 tablets
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-04-14
Actual start date
Estimated end date Unknown
Actual end date 2017-05-15
Shortage status Resolved
Updated date 2017-05-16
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-05-16 English Compare
v5 2017-05-15 French Compare
v4 2017-05-15 English Compare
v3 2017-04-15 English Compare
v2 2017-04-10 French Compare
v1 2017-04-10 English Compare